Wang, Litong – Trademark Portfolio
Entity Type: 01
Wang, Litong owns a portfolio of 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as EXHAIL, YOCOKA, DR.TOUR, JOYRAIN, and TECCHIC. Of these, 8 are registered and 4 are pending. The portfolio spans 7 Nice Classification classes, led by Class 11 (Environmental Control) and Class 9 (Computers & Electronics). Headquartered in Huainan,Anhui.
Tianjia'an District
17-3-10, Laolongyan Longyan Village
Huainan,Anhui 232000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wang, Litong's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Wang, Litong have?
Wang, Litong has 14 U.S. trademarks filed with the USPTO. Of these, 8 registered, 4 pending, 2 abandoned.
What trademark classes does Wang, Litong file in?
Wang, Litong files trademarks across 7 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 9 (Computers & Electronics), Class 21 (Housewares), Class 10 (Medical Apparatus), Class 12 (Vehicles). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are Wang, Litong's most well-known trademarks?
Wang, Litong's registered trademark portfolio includes well-known marks such as EXHAIL, YOCOKA, DR.TOUR, JOYRAIN, and TECCHIC. These are among 8 currently registered trademarks in the portfolio.
What is Wang, Litong's trademark registration success rate?
Wang, Litong has a 80% trademark registration rate, with 8 out of 10 resolved applications resulting in successful registration. Currently, 4 applications are pending review.